Yan Gao , Qi Sheng , Xinxin Shi , Xiangshu Qiu , Jiaqi Zhang , Xu Gao , He Zhang , Huijun Lu
{"title":"Japanese encephalitis virus envelope protein activates the TLR4/NF‑κB pathway to induce testicular inflammation","authors":"Yan Gao , Qi Sheng , Xinxin Shi , Xiangshu Qiu , Jiaqi Zhang , Xu Gao , He Zhang , Huijun Lu","doi":"10.1016/j.vetmic.2026.110969","DOIUrl":null,"url":null,"abstract":"<div><div>Japanese encephalitis virus (JEV), a mosquito-borne flavivirus, remains a leading cause of viral encephalitis in Asia and poses serious threats to reproductive health. However, the molecular mechanisms underlying JEV-induced testicular inflammation remain incompletely understood. In this study, an integrated approach involving proteomic, cellular, and animal experiments was used to investigate the role of Toll-like receptor 4 (TLR4) in JEV-triggered inflammatory responses. Proteomic analysis and in vitro assays revealed that JEV infection upregulated TLR4 expression and activated the NF‑κB signaling cascade, resulting in enhanced secretion of inflammatory cytokines, including TNF-α, IL-1β, and IL-6. Among the viral proteins examined, only the envelope (E) protein significantly increased endogenous TLR4 levels in a dose-dependent manner. Direct interaction between the E protein and TLR4 was confirmed by co-immunoprecipitation and immunofluorescence. In a mouse model of JEV infection, the virus induced severe testicular inflammation, characterized by tissue disruption, TLR4 upregulation, and activation of the TLR4/NF-κB pathway, consistent with the in vitro observations. Collectively, these findings identify the JEV E protein as a key inducer of TLR4-mediated inflammation and provide mechanistic insights into JEV-associated testicular pathology.</div></div>","PeriodicalId":23551,"journal":{"name":"Veterinary microbiology","volume":"316 ","pages":"Article 110969"},"PeriodicalIF":2.7000,"publicationDate":"2026-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Veterinary microbiology","FirstCategoryId":"97","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0378113526001008","RegionNum":2,"RegionCategory":"农林科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/3/7 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"MICROBIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Japanese encephalitis virus (JEV), a mosquito-borne flavivirus, remains a leading cause of viral encephalitis in Asia and poses serious threats to reproductive health. However, the molecular mechanisms underlying JEV-induced testicular inflammation remain incompletely understood. In this study, an integrated approach involving proteomic, cellular, and animal experiments was used to investigate the role of Toll-like receptor 4 (TLR4) in JEV-triggered inflammatory responses. Proteomic analysis and in vitro assays revealed that JEV infection upregulated TLR4 expression and activated the NF‑κB signaling cascade, resulting in enhanced secretion of inflammatory cytokines, including TNF-α, IL-1β, and IL-6. Among the viral proteins examined, only the envelope (E) protein significantly increased endogenous TLR4 levels in a dose-dependent manner. Direct interaction between the E protein and TLR4 was confirmed by co-immunoprecipitation and immunofluorescence. In a mouse model of JEV infection, the virus induced severe testicular inflammation, characterized by tissue disruption, TLR4 upregulation, and activation of the TLR4/NF-κB pathway, consistent with the in vitro observations. Collectively, these findings identify the JEV E protein as a key inducer of TLR4-mediated inflammation and provide mechanistic insights into JEV-associated testicular pathology.
期刊介绍:
Veterinary Microbiology is concerned with microbial (bacterial, fungal, viral) diseases of domesticated vertebrate animals (livestock, companion animals, fur-bearing animals, game, poultry, fish) that supply food, other useful products or companionship. In addition, Microbial diseases of wild animals living in captivity, or as members of the feral fauna will also be considered if the infections are of interest because of their interrelation with humans (zoonoses) and/or domestic animals. Studies of antimicrobial resistance are also included, provided that the results represent a substantial advance in knowledge. Authors are strongly encouraged to read - prior to submission - the Editorials (''Scope or cope'' and ''Scope or cope II'') published previously in the journal. The Editors reserve the right to suggest submission to another journal for those papers which they feel would be more appropriate for consideration by that journal.
Original research papers of high quality and novelty on aspects of control, host response, molecular biology, pathogenesis, prevention, and treatment of microbial diseases of animals are published. Papers dealing primarily with immunology, epidemiology, molecular biology and antiviral or microbial agents will only be considered if they demonstrate a clear impact on a disease. Papers focusing solely on diagnostic techniques (such as another PCR protocol or ELISA) will not be published - focus should be on a microorganism and not on a particular technique. Papers only reporting microbial sequences, transcriptomics data, or proteomics data will not be considered unless the results represent a substantial advance in knowledge.
Drug trial papers will be considered if they have general application or significance. Papers on the identification of microorganisms will also be considered, but detailed taxonomic studies do not fall within the scope of the journal. Case reports will not be published, unless they have general application or contain novel aspects. Papers of geographically limited interest, which repeat what had been established elsewhere will not be considered. The readership of the journal is global.